# Assess Cancer in Ovarian Tumors With Biomarkers.

> **NCT00436189** · NA · COMPLETED · sponsor: **Ciphergen Biosystems** · enrollment: 1000 (estimated)

## Conditions studied

- Ovarian Tumor

## Interventions

- **PROCEDURE:** Blood Draw

## Key facts

- **NCT ID:** NCT00436189
- **Lead sponsor:** Ciphergen Biosystems
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2008-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00436189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00436189, "Assess Cancer in Ovarian Tumors With Biomarkers.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00436189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*